3681SinoMab BioScience3681 info
$0.16info5.88%24h
Global rank18416
Market cap$167.32M
Change 7d10.53%
YTD Performance-23.64%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    SinoMab BioScience (3681) Stock Overview

    SinoMab BioScience Limited, a biopharmaceutical company, engages in the research, development, manufacture, and commercialization of therapeutics for the treatment of immunological diseases primarily monoclonal antibody (mAb)-based biologics. Its flagship product is SM03, a first-in-target anti-CD22 mAb, which is in Phase III clinical trial for the treatment of rheumatoid arthritis (RA), as well as in various clinical stages for other immunological diseases, such as systemic lupus erythematosus (SLE), Sjogren's syndrome (SS), and non-Hodgkin's lymphoma (NHL). The company also focuses on developing SN1011, a Bruton's tyrosine kinase inhibitor, which is in Phase II clinical trial for the treatment of pemphigus, as well as in phase 1 clinical trial to treat multiple sclerosis, SLE, and NMOSD. Its products under the preclinical stage comprise SM17 for the treatment of asthma, atopic dermatitis, and idiopathic pulmonary fibrosis; SM06 to treat RA, SLE, NMOSD, and SS; SM09 for the treatment of NHL and RA; and TNF2 for the treatment of autoimmune diseases. It operates in Mainland China, the Cayman Islands, and Hong Kong. SinoMab BioScience Limited was incorporated in 2001 and is headquartered in Pak Shek Kok, Hong Kong.

    3681 Stock Information

    Symbol
    3681
    Address
    No.15 Science Park West AvenueTai Po, Hong Kong
    Founded
    -
    Trading hours
    -
    Website
    https://www.sinomab.com
    Country
    🇭🇰 Hong Kong
    Phone Number
    852 3426 9833

    SinoMab BioScience (3681) Price Chart

    -
    Value:-

    SinoMab BioScience Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $0.16167298175019984
    N/A
    Market Cap
    $167.32M
    N/A
    Shares Outstanding
    1.03B
    N/A
    Employees
    233.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    © 2024 Topstocks.org